Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods

Introduction: Bronchiolitis Obliterans (BO) is one of the most important pulmonary complications of Hematopoietic Stem Cell Transplantation (HSCT). We decided to evaluate the prevalence and risk factors of BO in HSCT patients in the Shariati Hospital Oncology Research Center. Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Keyvan Gohari Moghadam, Bahareh Marghoob, Kamran Alimoghaddam, Shapour Shirani, Ardeshir Ghavamzadeh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-03-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/235
_version_ 1797722316624363520
author Keyvan Gohari Moghadam
Bahareh Marghoob
Kamran Alimoghaddam
Shapour Shirani
Ardeshir Ghavamzadeh
author_facet Keyvan Gohari Moghadam
Bahareh Marghoob
Kamran Alimoghaddam
Shapour Shirani
Ardeshir Ghavamzadeh
author_sort Keyvan Gohari Moghadam
collection DOAJ
description Introduction: Bronchiolitis Obliterans (BO) is one of the most important pulmonary complications of Hematopoietic Stem Cell Transplantation (HSCT). We decided to evaluate the prevalence and risk factors of BO in HSCT patients in the Shariati Hospital Oncology Research Center. Materials and Methods: Forty two patients, who had had HSCT for at least 6 months ago, completed the study. The diagnosis of BO was confirmed either by spirometry or inspiratory and expiratory views of HRCT with a FEV1/FVC lower than 75% or more than a 10% drop of FEV1/FVC from a baseline value and mosaic or air trapping on HRCT, respectively. Results: Nineteen out of forty two patients were BO, with a prevalence of 45.2%; seventeen cases by HRCT and eleven by spirometry criteria. Identified risk factors for BO were acute and chronic GVHD, age 21-40 yrs. Female donor to male recipient and unmatched genders. There was a strong negative predictve value of symptoms under age 20. Conclusion: Young patients under 20, without respiratory symptoms, need no further evaluation. Acute and chronic GVHD are again the main risk factors regarding female donors to male recipients within the age group of 21-40.
first_indexed 2024-03-12T09:45:49Z
format Article
id doaj.art-16f91ba84de742e8becab138af0a8853
institution Directory Open Access Journal
issn 2008-2207
language English
last_indexed 2024-03-12T09:45:49Z
publishDate 2010-03-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-16f91ba84de742e8becab138af0a88532023-09-02T12:52:39ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072010-03-0141Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic MethodsKeyvan Gohari Moghadam0Bahareh Marghoob1Kamran Alimoghaddam2Shapour Shirani3Ardeshir Ghavamzadeh4Pulmonoary Medicine Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranRadiology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranIntroduction: Bronchiolitis Obliterans (BO) is one of the most important pulmonary complications of Hematopoietic Stem Cell Transplantation (HSCT). We decided to evaluate the prevalence and risk factors of BO in HSCT patients in the Shariati Hospital Oncology Research Center. Materials and Methods: Forty two patients, who had had HSCT for at least 6 months ago, completed the study. The diagnosis of BO was confirmed either by spirometry or inspiratory and expiratory views of HRCT with a FEV1/FVC lower than 75% or more than a 10% drop of FEV1/FVC from a baseline value and mosaic or air trapping on HRCT, respectively. Results: Nineteen out of forty two patients were BO, with a prevalence of 45.2%; seventeen cases by HRCT and eleven by spirometry criteria. Identified risk factors for BO were acute and chronic GVHD, age 21-40 yrs. Female donor to male recipient and unmatched genders. There was a strong negative predictve value of symptoms under age 20. Conclusion: Young patients under 20, without respiratory symptoms, need no further evaluation. Acute and chronic GVHD are again the main risk factors regarding female donors to male recipients within the age group of 21-40.https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/235Hematopoetic Stem Cell TransplantationBronchiolitis OblitetransPulmonary Complications
spellingShingle Keyvan Gohari Moghadam
Bahareh Marghoob
Kamran Alimoghaddam
Shapour Shirani
Ardeshir Ghavamzadeh
Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
International Journal of Hematology-Oncology and Stem Cell Research
Hematopoetic Stem Cell Transplantation
Bronchiolitis Oblitetrans
Pulmonary Complications
title Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
title_full Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
title_fullStr Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
title_full_unstemmed Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
title_short Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
title_sort bronchiolitis obliterans following hematopoietic stem cell transplantation risk factors and diagnostic methods
topic Hematopoetic Stem Cell Transplantation
Bronchiolitis Oblitetrans
Pulmonary Complications
url https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/235
work_keys_str_mv AT keyvangoharimoghadam bronchiolitisobliteransfollowinghematopoieticstemcelltransplantationriskfactorsanddiagnosticmethods
AT baharehmarghoob bronchiolitisobliteransfollowinghematopoieticstemcelltransplantationriskfactorsanddiagnosticmethods
AT kamranalimoghaddam bronchiolitisobliteransfollowinghematopoieticstemcelltransplantationriskfactorsanddiagnosticmethods
AT shapourshirani bronchiolitisobliteransfollowinghematopoieticstemcelltransplantationriskfactorsanddiagnosticmethods
AT ardeshirghavamzadeh bronchiolitisobliteransfollowinghematopoieticstemcelltransplantationriskfactorsanddiagnosticmethods